296796-44-6

Basic information

• Product Name: PYRIDINE, 5-BROMO-2-(1H-TETRAZOL-1-YL)-
• Synonyms: PYRIDINE, 5-BROMO-2-(1H-TETRAZOL-1-YL)-;5-bromo-2-(1H-tetrazol-1-yl)pyridine;5-Bromo-2-tetrazol-1-yl-pyridine
• CAS NO: 296796-44-6
• Molecular Formula: C6H4BrN5
• Molecular Weight: 226.03
• Mol File: 296796-44-6.mol
• Article Data: 16

Chemical Properties

• Appearance: /
• CAS DataBase Reference: PYRIDINE, 5-BROMO-2-(1H-TETRAZOL-1-YL)-(CAS DataBase Reference)
• NIST Chemistry Reference: PYRIDINE, 5-BROMO-2-(1H-TETRAZOL-1-YL)-(296796-44-6)
• EPA Substance Registry System: PYRIDINE, 5-BROMO-2-(1H-TETRAZOL-1-YL)-(296796-44-6)

Safety Data

• Hazardous Substances Data: 296796-44-6(Hazardous Substances Data)

Upstream product

• 13534-97-9 6-bromopyridine-3-amine 
• 122-51-0 orthoformic acid triethyl ester 
• 1072-97-5 5-bromo-2-pyridylamine 
• 149-73-5 trimethyl orthoformate 
• 288-94-8 1H-tetrazole 
• 624-28-2 2,5-dibromopyridine 

Relevant articles and documents

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

The present invention provides compounds of Formula (I) and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylax

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

INHIBITORS OF RENAL OUTER MEDULLARY POTASSIUM CHANNEL

Disclosed are compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.